Key points
- BAS reporting is compliance; management reporting is decision-making
- Late visibility leads to late decisions which leads to underperformance and underinvestment
- Key value drivers to monitor monthly are margins, productivity, and working capital
When a pharmacy fails, it rarely does so suddenly. Most failures are slow. Profits look acceptable. Sales may even be growing. But underneath, cash tightens, margins thin and balance sheets weaken, often unnoticed until options are gone. All whilst decisions are being made with information that’s months out of date
That’s why the goal isn’t just better accounting. The goal is better decision‑making, in real time.
Most owners already receive monthly BAS reporting. The problem is BAS reporting is designed for compliance. It answers the question: “What do I owe and when?”
Monthly management reporting answers a different (and more valuable) question: “What should I do next to improve profitability, cash flow and equity, and how do I know it’s working?”
The difference matters because in today’s environment, profitability is increasingly won or lost in the small decisions: roster mix, wage efficiency, category performance, stock levels, discounting discipline, and debt reduction, all of which need timely visibility.
Below is a practical playbook built from Pitcher Partners’ pharmacy industry averages (2021–2025).
1. Start with the story behind the numbers (sales up, pressure building)
Average sales increased 26% from 2021 to 2025 . That’s good news, but it’s not the full story.
Across the same period, gross margin has tightened in both key engines of the business:
- Dispensary GP% moved from 36.8% (2021) to 31.4% (2025), largely a result of the increase in the average script price and owners need to understand what is driving this.
- Retail GP% (incl S2/S3) moved from 37.3% (2021) to 34.5% (2025) and again, owners need to understand the drivers as they are different to those in the dispensary.
What this means for owners: you can’t manage the business on revenue alone. When margins tighten, the winners are the owners who can see why, early, and adjust quickly.
2. BAS reporting tells you what happened. Management reporting helps you change what happens next.
If your main monthly rhythm is BAS, your visibility is largely confined to tax and cash movements. Useful, but incomplete.
A management reporting pack is different because it is built for decisions. It typically includes:
- A clear view of performance (sales, margin, expenses) with trend and variance.
- A balance‑sheet view of pressure points (stock, creditors, debt, and cash movements).
- Practical KPIs that reveal drivers, not just results.
- Benchmark context — so you know whether a movement is ‘normal for the industry’ or a signal to act.
In other words: BAS reporting is a compliance snapshot. Management reporting is a steering wheel.
The cost of not acting: underperformance becomes underinvestment
When you don’t see issues early, you tend to respond late, and late responses usually mean fewer options. Over time, underperformance doesn’t just reduce profit; it reduces capacity to invest.
It shows up as delayed refits, postponed consult rooms/professional services, and deferred systems and staff capability, all whilst customer expectations are rising. Often owners are choosing safe decisions (do nothing, hold cash) because the numbers arrive too late to support confident action.
Pharmacies that keep investing in the store, professional services and productivity, are typically the ones that protect their position and valuation.
3. Put wages and overheads on a scoreboard (and keep it current)
From 2021 to 2025, the industry averages show how important cost discipline has become:
- Expenses per m² rose from $4,358 (2021) to $4,938 (2025).
- Whilst wages to sales improved from 14.8% (2021) to 13.8% (2025), largely due to inflation being higher than wage growth, a declining GP% meant that wages to GP$ + service income was relatively unchanged from 40.8% (2021) to 40.4% (2025).
This is where timely reporting matters most. A month or more late view of wages and expenses is like checking your fuel gauge after you’ve driven past the exit.
Practical tip: track wages and overheads using ‘per unit’ measures that connect to activity, for example, cost per FTE, customers per FTE, expenses per m², and expenses as a % of sales or GP$. These metrics are far more actionable than a once‑a‑month total.
4. Watch the leading indicators: customers, scripts, and capacity utilisation
The averages show that volume can soften even when sales hold up:
- Customer numbers have declined 0.03% from 2024 to 2025.
- Script volume has declined 0.94% from 2024 to 2025, assisted to by the increase in 60-day dispensing
- Scripts per customer have reduced from 0.83 (2021) to 0.74 (2025).
When volume softens, the question becomes: are we ‘right‑sized’ for the new reality? This is not an accounting question, it’s a commercial one.
Practical tip: a strong management pack lets you see capacity utilisation early: what labour is producing, where service delivery is underleveraged, and which levers (rosters, workflow, retail focus, professional services) can lift productivity without lifting risk.
5. Convert profit into equity (the wealth step many owners skip)
Strong years should create stronger balance sheets.
In the averages, EBIT per m² strengthened from 2021 to 2024 though profit per customer decreased from $3.98 (2021) to $3.91 (2024).
The key is what happens next: profit must become cash, and cash must be directed. The simplest equity plan is:
- Lock in a monthly debt reduction target while profits are strong.
- Keep a clear view of working capital so cash doesn’t get trapped.
- Build equity deliberately; so you fund optionality (growth, succession, reinvestment) from strength, not stress.
Practical tip: set one rule that runs every month: “A fixed amount of free cash flow goes to debt reduction.” This single discipline changes the long‑term wealth outcome for many owners.
6. Treat working capital as a profit lever (especially stock)
Inventory is often where ‘quiet’ balance sheet pressure builds first.
Across the averages:
- The average retail stock on hand increased 31% from 2021 to 2025.
- Retail stock intensity (the value of stock per retail m²) rose from $1,119 (2021) to $1,519 (2025).
If your reporting is delayed, stock growth can look like ‘being well supplied’ right up until cash tightens. Slow-moving stock can quietly accumulate (particularly in retail categories), tying up cash and eroding liquidity.
Timely management reporting keeps stock, creditors and cash movements visible so owners can act early.
What ‘quality and timely management reporting’ really means (without the jargon)
Good management reporting isn’t about thicker reports. It’s about faster, clearer decisions.
A great monthly pack should help an owner answer four questions quickly:
- What changed this month (and why)?
- Which levers should I pull next month?
- Where is cash building — and where is it getting stuck?
- How do I compare to my peers, and what does that imply for my strategy?
At Pitcher Partners, we support pharmacy owners with data‑led insights and monthly management reporting that brings these questions forward, from ‘year end’ into the month where decisions are actually made.
What’s next?
If you’re currently relying on monthly BAS outcomes as your primary scorecard, consider adding a management reporting rhythm that includes industry benchmarks and balance sheet visibility. In our experience, it’s one of the simplest ways to improve decision quality, protect profitability, and turn strong trading into stronger equity. The cost difference is negligible while the value difference is seismic.
If you’re at APP2026, visit us at Stand F8 in the foyer for a demonstration of PharmaCFO, our monthly management reporting solution.
